TET蛋白家族与5-羟甲基胞嘧啶在干细胞及再生医学表观遗传调控中的作用

doi:10.19723/j.issn.1671-167X.2021.02.032

摘要/Abstract

Abstract:

The methylation of cytosine is one of the most fundamental epigenetic modifications in mammalian genomes, and is involved in multiple crucial processes including gene expression, cell differentiation, embryo development and oncogenesis. In the past, DNA methylation was thought to be an irreversible process, which could only be diluted passively through DNA replication. It is now becoming increa-singly obvious that DNA demethylation can be an active process and plays a crucial role in biological processes. Ten eleven translocation (TET) proteins are the key factors modulating DNA demethylation. This family contains three members: TET1, TET2 and TET3. Although three TET proteins have relatively conserved catalytic domains, their roles in organisms are not repeated, and their expression has significant cell/organ specificity. TET1 is mainly expressed in embryonic stem cells, TET2 is mainly expressed in hematopoietic system, and TET3 is widely expressed in cerebellum, cortex and hippocampus. This family catalyzes 5-methylcytosine to 5-hydroxymethylcytosine and other oxidative products, reactivates silenced-gene expression, in turn maintains stem cell pluripotency and regulates lineage specification. With the development of tissue engineering, organ transplantation, autologous tissue transplantation and artificial prosthesis have been widely used in clinical treatment, but these technologies have limitations. Regenerative medicine, which uses stem cells and stem cell related factors for treatment, may provide alternative therapeutic strategies for multiple diseases. Among all kinds of human stem cells, adipose-derived stem cells (ADSCs) are the most prospective stem cell lineage since they have no ethical issues and can be easily obtained with large quantities. To date, ADSCs have been shown to have strong proli-feration capacity, secrete numerous soluble factors and have multipotent differentiation ability. However, the underlying mechanism of the proliferation, secretion, acquired pluripotency, and lineage specific differentiation of ADSCs are still largely unknown. Some studies have explored the role of epigenetic regulation and TET protein in embryonic stem cells, but little is known about its role in ADSCs. By studying the roles of TET proteins and 5-hydroxymethylcytosine in ADSCs, we could provide new theoretical foundation for the clinical application of ADSCs and the stem cell-based therapy. In the future, combined with bioprinting technology, ADSCs may be used in tissue and organ regeneration, plastic surgery reconstruction and other broader fields.

Key words: Ten eleven translocation protein, 5-hydroxymethylcytosine, Adipose-derived stem cell, Regenerative medicine

中图分类号:

R622

赵健芳,李东,安阳. TET蛋白家族与5-羟甲基胞嘧啶在干细胞及再生医学表观遗传调控中的作用[J]. 北京大学学报（医学版）, 2021, 53(2): 420-424.

ZHAO Jian-fang,LI Dong,AN Yang. Roles of ten eleven translocation proteins family and 5-hydroxymethylcytosine in epigenetic regulation of stem cells and regenerative medicine[J]. Journal of Peking University (Health Sciences), 2021, 53(2): 420-424.

图/表 2

图1

图2

参考文献 42

[1]	Andrews AJ, Luger K. Nucleosome structure(s) and stability: variations on a theme[J]. Annu Rev Biophys, 2011,40:99-117. doi: 10.1146/annurev-biophys-042910-155329 pmid: 21332355
[2]	Bird A. DNA methylation patterns and epigenetic memory[J]. Genes Dev, 2002,16(1):6-21. doi: 10.1101/gad.947102 pmid: 11782440
[3]	An J, Rao A, Ko M. TET family dioxygenases and DNA demethylation in stem cells and cancers[J]. Exp Mol Med, 2017,49(4):e323. doi: 10.1038/emm.2017.5 pmid: 28450733
[4]	Mizuno H, Tobita M, Uysal AC. Concise review: Adipose-derived stem cells as a novel tool for future regenerative medicine[J]. Stem Cells, 2012,30(5):804-810. doi: 10.1002/stem.1076 pmid: 22415904
[5]	Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics[J]. Nat Rev Genet, 2008,9(6):465-476. doi: 10.1038/nrg2341 pmid: 18463664
[6]	Kafri T, Ariel M, Brandeis M, et al. Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line[J]. Genes Dev, 1992,6(5):705-714. doi: 10.1101/gad.6.5.705 pmid: 1577268
[7]	Huang Y, Rao A. Connections between TET proteins and aberrant DNA modification in cancer[J]. Trends Genet, 2014,30(10):464-474. doi: 10.1016/j.tig.2014.07.005
[8]	Tahiliani M, Koh KP, Shen Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1[J]. Science, 2009,324(5929):930-935. doi: 10.1126/science.1170116 pmid: 19372391
[9]	Ito S, Shen L, Dai Q, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine[J]. Science, 2011,333(6047):1300-1303. doi: 10.1126/science.1210597
[10]	Shi DQ, Ali I, Tang J, et al. New insights into 5hmC DNA modification: generation, distribution and function[J]. Front Genet, 2017,8:100. pmid: 28769976
[11]	Rasmussen KD, Helin K. Role of TET enzymes in DNA methylation, development, and cancer[J]. Genes Dev, 2016,30(7):733-750. doi: 10.1101/gad.276568.115 pmid: 27036965
[12]	Ono R, Taki T, Taketani T, et al. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10, 11)(q22;q23)[J]. Cancer Res, 2002,62(14):4075-4080. pmid: 12124344
[13]	Ito S, D’Alessio AC, Taranova OV, et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification[J]. Nature, 2010,466(7310):1129-1133. doi: 10.1038/nature09303 pmid: 20639862
[14]	Nestor CE, Ottaviano R, Reddington J, et al. Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes[J]. Genome Res, 2012,22(3):467-477. doi: 10.1101/gr.126417.111
[15]	Wyatt GR, Cohen SS. A new pyrimidine base from bacteriophage nucleic acids[J]. Nature, 1952,170(4338):1072-1073. doi: 10.1038/1701072a0 pmid: 13013321
[16]	Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain[J]. Science, 2009,324(5929):929-930. doi: 10.1126/science.1169786 pmid: 19372393
[17]	Globisch D, Munzel M, Muller M, et al. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates[J]. PLoS One, 2010,5(12):e15367. pmid: 21203455
[18]	Wu H, Zhang Y. Reversing DNA methylation: mechanisms, genomics, and biological functions[J]. Cell, 2014,156(1/2):45-68. doi: 10.1016/j.cell.2013.12.019
[19]	Challen GA, Sun D, Jeong M, et al. Dnmt3a is essential for hematopoietic stem cell differentiation[J]. Nat Genet, 2011,44(1):23-31. pmid: 22138693
[20]	Pfaffeneder T, Hackner B, Truss M, et al. The discovery of 5-formylcytosine in embryonic stem cell DNA[J]. Angew Chem Int Ed Engl, 2011,50(31):7008-7012. doi: 10.1002/anie.201103899 pmid: 21721093
[21]	Pastor WA, Pape UJ, Huang Y, et al. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells[J]. Nature, 2011,473(7347):394-397. doi: 10.1038/nature10102 pmid: 21552279
[22]	Ficz G, Branco MR, Seisenberger S, et al. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation[J]. Nature, 2011,473(7347):398-402. doi: 10.1038/nature10008 pmid: 21460836
[23]	Lu F, Liu Y, Jiang L, et al. Role of Tet proteins in enhancer activity and telomere elongation[J]. Genes Dev, 2014,28(19):2103-2119. doi: 10.1101/gad.248005.114 pmid: 25223896
[24]	Izadpanah R, Trygg C, Patel B, et al. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue[J]. J Cell Biochem, 2006,99(5):1285-1297. doi: 10.1002/jcb.20904 pmid: 16795045
[25]	Mizuno H. Adipose-derived stem and stromal cells for cell-based therapy: current status of preclinical studies and clinical trials[J]. Curr Opin Mol Ther, 2010,12(4):442-449. pmid: 20677095
[26]	Kim WS, Park BS, Sung JH. Protective role of adipose-derived stem cells and their soluble factors in photoaging[J]. Arch Dermatol Res, 2009,301(5):329-336. doi: 10.1007/s00403-009-0951-9 pmid: 19396609
[27]	Yoshimura K, Sato K, Aoi N, et al. Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells[J]. Aesthetic Plast Surg, 2008,32(1):48-55. doi: 10.1007/s00266-007-9019-4 pmid: 17763894
[28]	Paduano F, Marrelli M, Amantea M, et al. Adipose tissue as a strategic source of mesenchymal stem cells in bone regeneration: a topical review on the most promising craniomaxillofacial applications[J]. Int J Mol Sci, 2017,18(10):2140. doi: 10.3390/ijms18102140
[29]	Rigotti G, Marchi A, Galie M, et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells[J]. Plast Reconstr Surg, 2007,119(5):1409-1422. doi: 10.1097/01.prs.0000256047.47909.71 pmid: 17415234
[30]	Akita S, Akino K, Hirano A, et al. Mesenchymal stem cell therapy for cutaneous radiation syndrome[J]. Health Phys, 2010,98(6):858-862. doi: 10.1097/HP.0b013e3181d3d52c pmid: 20445394
[31]	Li Y, Zhang W, Gao J, et al. Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway[J]. Stem Cell Res Ther, 2016,7(1):102. doi: 10.1186/s13287-016-0356-6 pmid: 27484727
[32]	Seeliger C, Culmes M, Schyschka L, et al. Decrease of global methylation improves significantly hepatic differentiation of Ad-MSCs: possible future application for urea detoxification[J]. Cell Transplant, 2013,22(1):119-131. pmid: 22507189
[33]	Tan SJ, Fang JY, Wu Y, et al. Muscle tissue engineering and regeneration through epigenetic reprogramming and scaffold mani-pulation[J]. Sci Rep, 2015,5:16333. doi: 10.1038/srep16333 pmid: 26548559
[34]	Zhang RP, Shao JZ, Xiang LX. GADD45A protein plays an essential role in active DNA demethylation during terminal osteogenic differentiation of adipose-derived mesenchymal stem cells[J]. J Biol Chem, 2011,286(47):41083-41094. doi: 10.1074/jbc.M111.258715 pmid: 21917922
[35]	Yan X, Ehnert S, Culmes M, et al. 5-azacytidine improves the osteogenic differentiation potential of aged human adipose-derived mesenchymal stem cells by DNA demethylation[J]. PLoS One, 2014,9(6):e90846. doi: 10.1371/journal.pone.0090846 pmid: 24603866
[36]	Daniunaite K, Serenaite I, Misgirdaite R, et al. Epigenetic regulation of human adipose-derived stem cells differentiation[J]. Mol Cell Biochem, 2015,410(1/2):111-120. doi: 10.1007/s11010-015-2543-7
[37]	Kornicka K, Marycz K, Maredziak M, et al. The effects of the DNA methyltranfserases inhibitor 5-Azacytidine on ageing, oxidative stress and DNA methylation of adipose derived stem cells[J]. J Cell Mol Med, 2017,21(2):387-401. pmid: 27998022
[38]	Marycz K, Kornicka K, Irwin-Houston JM, et al. Combination of resveratrol and 5-Azacytidine improves osteogenesis of metabolic syndrome mesenchymal stem cells[J]. J Cell Mol Med, 2018,22(10):4771-4793. doi: 10.1111/jcmm.13731 pmid: 29999247
[39]	Kornicka K, Szlapka-Kosarzewska J, Smieszek A, et al. 5-Azacytidine and resveratrol reverse senescence and ageing of adipose stem cells via modulation of mitochondrial dynamics and autophagy[J]. J Cell Mol Med, 2019,23(1):237-259. doi: 10.1111/jcmm.13914 pmid: 30370650
[40]	Yoo Y, Park JH, Weigel C, et al. TET-mediated hydroxymethylcytosine at the PPARgamma locus is required for initiation of adipogenic differentiation[J]. Int J Obes (Lond), 2017,41(4):652-659. doi: 10.1038/ijo.2017.8
[41]	Fujiki K, Shinoda A, Kano F, et al. PPARgamma-induced PARylation promotes local DNA demethylation by production of 5-hydroxymethylcytosine[J]. Nat Commun, 2013,4:2262. doi: 10.1038/ncomms3262 pmid: 23912449
[42]	Dubois-Chevalier J, Staels B, Lefebvre P, et al. The ubiquitous transcription factor CTCF promotes lineage-specific epigenomic remodeling and establishment of transcriptional networks driving cell differentiation[J]. Nucleus, 2015,6(1):15-18. pmid: 25565413

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed